Literature DB >> 11160316

Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5'-monophosphate response elements in its expression by IL-1 and stem cell factor.

J Qian1, G Yehia, C Molina, A Fernandes, R Donnelly, D Anjaria, P Gascon, P Rameshwar.   

Abstract

Preprotachykinin-I gene (PPT-I) encodes several peptides with organ-specific functions that link the neuroendocrine-immune-hemopoietic axis. We cloned upstream of the initiation site of human PPT-I promoter and identified consensus sequences for two cAMP response elements (CRE). PPT-I is induced by cytokines including those that signal through the cAMP pathway. Therefore, we studied the role of the two CRE in IL-1alpha and stem cell factor (SCF) stimulation of bone marrow stroma because both cytokines induce endogenous PPT-I in these cells and activate the cAMP pathway. Furthermore, bone marrow stroma expresses the transcription factors regulated by the cAMP pathways such as the repressor (ICERIIgamma) and activator (CREMtau). Mutagenesis of the two CRE and/or cotransfection with vectors that express ICERIIgamma or CREMtau indicated that the two CRE have major roles in PPT-I expression. The two CRE are also required for optimal promoter activity by SCF and IL-1alpha. A particular cytokine could concomitantly induce PPT-I and the high affinity G protein-coupled receptor for PPT-I peptides, NK-1R. We showed that SCF, a representative cytokine, induced PPT-I and NK-1R leading to autocrine and/or paracrine cell activation. Because NK-1R activates cAMP through the G protein, the results suggest that the presence of CRE sequences within PPT-I promoter could be important in the regulation of PPT-I expression by cytokines, irrespective of their ability to signal through cAMP. As PPT-I is implicated in hemopoietic regulation, immune responses, breast cancer, and other neural functions, these studies add to the basic biology of these processes and could provide targets for drug development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160316     DOI: 10.4049/jimmunol.166.4.2553

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Role of neurokinin-1 receptor in the initiation and maintenance of skin chronic inflammatory diseases.

Authors:  Sherrie J Divito; Adrian E Morelli; Adriana T Larregina
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

2.  Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish.

Authors:  Nitixa Patel; Tilman E Klassert; Steven J Greco; Shyam A Patel; Jessian L Munoz; Bobby Y Reddy; Margarette Bryan; Neil Campbell; Natalia Kokorina; Hatem E Sabaawy; Pranela Rameshwar
Journal:  Stem Cells Dev       Date:  2011-07-26       Impact factor: 3.272

3.  The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential.

Authors:  Tammy A Castro; Marion C Cohen; Pranela Rameshwar
Journal:  Clin Exp Metastasis       Date:  2006-04-27       Impact factor: 5.150

4.  Autocrine proliferation of neuroblastoma cells is partly mediated through neurokinin receptors: relevance to bone marrow metastasis.

Authors:  Indroneil Mukerji; Shakti H Ramkissoon; Kavitha K R Reddy; Pranela Rameshwar
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

5.  MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells.

Authors:  Steven J Greco; Pranela Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-13       Impact factor: 11.205

6.  An indirect role for oncomir-519b in the expression of truncated neurokinin-1 in breast cancer cells.

Authors:  Peter Navarro; Shakti H Ramkissoon; Simant Shah; Jacqueline M Park; Raghav G Murthy; Shyam A Patel; Steven J Greco; Pranela Rameshwar
Journal:  Exp Cell Res       Date:  2012-09-12       Impact factor: 3.905

7.  Specific N-cadherin-dependent pathways drive human breast cancer dormancy in bone marrow.

Authors:  Garima Sinha; Alejandra I Ferrer; Seda Ayer; Markos H El-Far; Sri Harika Pamarthi; Yahaira Naaldijk; Pradeep Barak; Oleta A Sandiford; Bernadette M Bibber; Ghassan Yehia; Steven J Greco; Jie-Gen Jiang; Margarette Bryan; Rakesh Kumar; Nicholas M Ponzio; Jean-Pierre Etchegaray; Pranela Rameshwar
Journal:  Life Sci Alliance       Date:  2021-06-02

8.  RE-1-silencing transcription factor shows tumor-suppressor functions and negatively regulates the oncogenic TAC1 in breast cancer cells.

Authors:  Bobby Y Reddy; Steven J Greco; Prem S Patel; Katarzyna A Trzaska; Pranela Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-25       Impact factor: 11.205

9.  P2Y receptors and pain transmission.

Authors:  Zoltan Gerevich; Peter Illes
Journal:  Purinergic Signal       Date:  2004-12       Impact factor: 3.765

10.  Role of human HGFIN/nmb in breast cancer.

Authors:  Rebecca L Metz; Prem S Patel; Meera Hameed; Margaret Bryan; Pranela Rameshwar
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.